HealthEquity, Inc. (NASDAQ:HQY) Shares Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. grew its position in HealthEquity, Inc. (NASDAQ:HQY) by 7,983.6% during the first quarter, Holdings Channel reports. The firm owned 24,655 shares of the company’s stock after acquiring an additional 24,350 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in HealthEquity were worth $2,179,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Transce3nd LLC purchased a new stake in shares of HealthEquity in the fourth quarter worth about $29,000. Versant Capital Management Inc purchased a new stake in shares of HealthEquity in the first quarter worth about $28,000. Smartleaf Asset Management LLC boosted its stake in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares during the last quarter. Skandinaviska Enskilda Banken AB publ boosted its stake in shares of HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after buying an additional 445 shares during the last quarter. Finally, Lindbrook Capital LLC boosted its stake in shares of HealthEquity by 27.6% in the fourth quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock worth $72,000 after buying an additional 162 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HQY. Bank of America upped their target price on HealthEquity from $110.00 to $125.00 and gave the stock a “buy” rating in a research note on Wednesday, June 4th. JMP Securities upped their target price on HealthEquity from $110.00 to $117.00 and gave the stock a “market outperform” rating in a research note on Wednesday, June 4th. The Goldman Sachs Group upped their target price on HealthEquity from $94.00 to $104.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 4th. Raymond James Financial upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $98.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, June 5th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $118.09.

Insider Activity

In other news, Director Jon Kessler sold 134,183 shares of the firm’s stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.08, for a total value of $15,039,230.64. Following the transaction, the director owned 253,510 shares in the company, valued at $28,413,400.80. This trade represents a 34.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the transaction, the director owned 84,969 shares in the company, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 295,700 shares of company stock worth $32,968,990 over the last quarter. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Stock Performance

Shares of HQY stock opened at $99.55 on Friday. The company has a market capitalization of $8.61 billion, a P/E ratio of 72.66, a P/E/G ratio of 1.56 and a beta of 0.49. The business’s 50 day moving average is $99.47 and its two-hundred day moving average is $98.18. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. The business had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter last year, the business posted $0.80 earnings per share. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.